After operating for over 24 years, we are expanding our expertise in the UK, Trent Gateway is Upperton’s newest facility offering a tenfold increase in our drug development and manufacturing capacity.
This new state-of-the-art Nottingham site brings 10 new GMP manufacturing suites, quality control laboratories and dedicated analytical and formulation development laboratories with pilot plant facilities. With greater capabilities and the latest technological advancements, Trent Gateway offers faster turnaround times, increased efficiency and greater flexibility to accommodate your ever-evolving pharmaceutical needs.
Trent Gateway has been specifically designed to cater to a wide range of development and manufacturing projects, offering processing of non-sterile dosage forms including solids, liquids, semi-solids, nasal and inhaled products.
Whether you’re in the early stages of formulation development, in need of clinical trial supplies from Phase 1 to Phase 3 or seeking niche-scale commercial manufacturing, Trent Gateway is fully equipped to fulfil your requirements with precision and excellence.
Upperton completes build of new £15m development and GMP manufacturing facility Nottingham : 12th July 2023 Leading UK contract development and manufacturing organisation (CDMO), Upperton
20th April 2023 – Upperton Increases Oral Dosage Form Capabilities at its Nottingham HQ Nottingham, UK, 20th April: Leading UK contract development and manufacturing organisation
Upperton Pharma Solutions breaks ground on new Nottingham based development and manufacturing facility Nottingham : 18th January 2023 Upperton Pharma Solutions, a leading UK contract
Upperton Pharma Solutions is an early phase Pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with more than twenty years of experience in the development of pharmaceutical dosage forms.
Albert Einstein Centre, Nottingham Science Park, Nottingham, UK NG7 2TN,
Phone: +44 (0) 115 855 7050
Email: contact@upperton.com